Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on January 31st, 2019%
A biotechnology company is engaging the services of a children’s cancer researcher to develop an antibody for treating neuroblastoma, a type of cancer that affects the nervous system. . . . → Read More: Biotech, Univ. Lab Partner on Cancer Antibodies
By Alan, on January 31st, 2019%
An ingestible gel capsule is shown in tests with animals to expand and reside in the stomach for as long as a month for delivering drugs or monitoring bodily functions. . . . → Read More: Expanding Gel Pill Designed for Long-Term Diagnostics
By Alan, on January 31st, 2019% The quest is on for new technologies, food production techniques, and behavioral change in developed countries that will help us feed everyone. . . . → Read More: Relying on Tech to Feed India, Africa, and China
By Alan, on January 30th, 2019%
Two international health organizations are making 400 compounds freely available to researchers to spur development of new drugs for pandemic infectious diseases. . . . → Read More: Compounds Made Available for Pandemic Drug Discovery
By Alan, on January 30th, 2019%
A large-scale clinical trial testing immunotherapy drugs to treat specific types of lung cancer is expanding to include all of the most common forms of the disease. . . . → Read More: Precision Lung Cancer Trial Expands Scope
By Alan, on January 30th, 2019% We’ve put together some tips for those who are interested in the world of startups, but want to see the results on a budget. . . . → Read More: Money Savvy Tips For New Startups
By Alan, on January 29th, 2019%
An academic-industry team of researchers and engineers is studying better ways of structuring the large volumes of data storage needed to speed up genomic sequencing. . . . → Read More: Data Architecture Studied to Speed Genomic Sequencing
By Alan, on January 29th, 2019%
A new initiative is researching modified immune system cells to treat T-cell lymphoma, a type of blood-related cancer, with a simpler, lower-cost process. . . . → Read More: Foundation Backs Engineered T-Cells to Treat Lymphoma
By Alan, on January 29th, 2019% Here are a few ways to build an online presence. . . . → Read More: Build an Online Presence Beyond a Web Site
By Alan, on January 28th, 2019%
A clinical trial assessing stem cell treatments to repair long-term damage to brain cells from a stroke recruited its first patient. . . . → Read More: Trial Underway Testing Stem Cells for Stroke Repair
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|